These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32280029)

  • 1. Tau pathology in early Alzheimer's disease is linked to selective disruptions in neurophysiological network dynamics.
    Kocagoncu E; Quinn A; Firouzian A; Cooper E; Greve A; Gunn R; Green G; Woolrich MW; Henson RN; Lovestone S; ; Rowe JB
    Neurobiol Aging; 2020 Aug; 92():141-152. PubMed ID: 32280029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
    Cope TE; Rittman T; Borchert RJ; Jones PS; Vatansever D; Allinson K; Passamonti L; Vazquez Rodriguez P; Bevan-Jones WR; O'Brien JT; Rowe JB
    Brain; 2018 Feb; 141(2):550-567. PubMed ID: 29293892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's pathology targets distinct memory networks in the ageing brain.
    Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
    Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
    Malpetti M; Kievit RA; Passamonti L; Jones PS; Tsvetanov KA; Rittman T; Mak E; Nicastro N; Bevan-Jones WR; Su L; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2020 May; 143(5):1588-1602. PubMed ID: 32380523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
    Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
    Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
    Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
    Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Networks of tau distribution in Alzheimer's disease.
    Hoenig MC; Bischof GN; Seemiller J; Hammes J; Kukolja J; Onur ÖA; Jessen F; Fliessbach K; Neumaier B; Fink GR; van Eimeren T; Drzezga A
    Brain; 2018 Feb; 141(2):568-581. PubMed ID: 29315361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
    Tosun D; Landau S; Aisen PS; Petersen RC; Mintun M; Jagust W; Weiner MW;
    Brain; 2017 May; 140(5):1499-1512. PubMed ID: 28334939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.
    Maass A; Landau S; Baker SL; Horng A; Lockhart SN; La Joie R; Rabinovici GD; Jagust WJ;
    Neuroimage; 2017 Aug; 157():448-463. PubMed ID: 28587897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Schumacher J; Gunter JL; Przybelski SA; Jones DT; Graff-Radford J; Savica R; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Knopman DS; Fields JA; Kremers WK; Petersen RC; Graff-Radford NR; Ferman TJ; Boeve BF; Thomas AJ; Taylor JP; Kantarci K
    Brain; 2021 Nov; 144(10):3212-3225. PubMed ID: 34114602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau-related grey matter network breakdown across the Alzheimer's disease continuum.
    Pelkmans W; Ossenkoppele R; Dicks E; Strandberg O; Barkhof F; Tijms BM; Pereira JB; Hansson O
    Alzheimers Res Ther; 2021 Aug; 13(1):138. PubMed ID: 34389066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease.
    Cho H; Choi JY; Lee SH; Lee JH; Choi YC; Ryu YH; Lee MS; Lyoo CH
    Neurobiol Aging; 2017 May; 53():103-111. PubMed ID: 28254589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum.
    Jones DT; Graff-Radford J; Lowe VJ; Wiste HJ; Gunter JL; Senjem ML; Botha H; Kantarci K; Boeve BF; Knopman DS; Petersen RC; Jack CR
    Cortex; 2017 Dec; 97():143-159. PubMed ID: 29102243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    King-Robson J; Wilson H; Politis M;
    J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective impairment of hippocampus and posterior hub areas in Alzheimer's disease: an MEG-based multiplex network study.
    Yu M; Engels MMA; Hillebrand A; van Straaten ECW; Gouw AA; Teunissen C; van der Flier WM; Scheltens P; Stam CJ
    Brain; 2017 May; 140(5):1466-1485. PubMed ID: 28334883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.
    Schöll M; Ossenkoppele R; Strandberg O; Palmqvist S; ; Jögi J; Ohlsson T; Smith R; Hansson O
    Brain; 2017 Sep; 140(9):2286-2294. PubMed ID: 29050382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional connectivity associated with tau levels in ageing, Alzheimer's, and small vessel disease.
    Franzmeier N; Rubinski A; Neitzel J; Kim Y; Damm A; Na DL; Kim HJ; Lyoo CH; Cho H; Finsterwalder S; Duering M; Seo SW; Ewers M;
    Brain; 2019 Apr; 142(4):1093-1107. PubMed ID: 30770704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study.
    Mattsson N; Ossenkoppele R; Smith R; Strandberg O; Ohlsson T; Jögi J; Palmqvist S; Stomrud E; Hansson O
    Alzheimers Res Ther; 2018 Aug; 10(1):77. PubMed ID: 30086796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.